Open Access

Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study

  • Authors:
    • Adriana-Teodora Campeanu
    • Mihaela Rus
    • Sorina Ispas
    • Alexandra Herlo
    • Aurora Craciun
    • Constantin Ionescu
    • Gheorghe-Mihail Banariu
    • Claudia-Simona Cambrea
    • Maria Nicolae
    • Andreea Nelson‑Twakor
    • Irina-Magdalena Dumitru
  • View Affiliations

  • Published online on: April 10, 2024     https://doi.org/10.3892/mi.2024.154
  • Article Number: 30
  • Copyright : © Campeanu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Systemic disorders may exhibit early signs when conducting an oral examination. Since the onset of the COVID‑19 pandemic, several studies have been published detailing the direct impact of the virus on the oral cavity. The present study aimed to determine whether indeed there are any significant disparities in oropharyngeal manifestations between individuals infected with severe acute respiratory syndrome coronavirus 2 and a control group, and whether the virus has the ability to invade and reproduce inside oral keratinocytes and fibroblasts, resulting in the development of oral ulcerations and superficial lesions. The present study provides an overview of the symptoms that occur at an early stage of the illness, and the most commonly affected regions of the oral cavity, including the tongue, lips, palate and oropharynx are examined. In the present retrospective study, 52 patients infected with COVID‑19 were recruited between April, 2021 and October, 2022. In addition, 52 individuals who tested negative for the virus were recruited as the control group. The study was conducted through a thorough examination and questionnaire provided to all participants. The results revealed that among the cohort of patients from the COVID‑19 group examined (n=52), a proportion (mean, 16.15) displayed oral manifestations. Specifically, 75% of the patients in the COVID‑19 group described oral cavity pain, and 69% of these patients had changes in teeth color or dental caries. In summary, in relation to the control group, the prevalence of oropharyngeal symptoms was generally lower compared to the COVID‑19 group, apart from oral cavity pain (30.8%), tonsillitis (17.3%), bleeding (34.6%), teeth color changes (36.5%), recurrence (15.4%) and abscesses (7.7%). Thus, on the whole, the patients without COVID‑19 had fewer oral manifestations.
View Figures
View References

Related Articles

Journal Cover

May-June 2024
Volume 4 Issue 3

Print ISSN: 2754-3242
Online ISSN:2754-1304

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Campeanu A, Rus M, Ispas S, Herlo A, Craciun A, Ionescu C, Banariu G, Cambrea C, Nicolae M, Nelson‑Twakor A, Nelson‑Twakor A, et al: Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study. Med Int 4: 30, 2024
APA
Campeanu, A., Rus, M., Ispas, S., Herlo, A., Craciun, A., Ionescu, C. ... Dumitru, I. (2024). Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study. Medicine International, 4, 30. https://doi.org/10.3892/mi.2024.154
MLA
Campeanu, A., Rus, M., Ispas, S., Herlo, A., Craciun, A., Ionescu, C., Banariu, G., Cambrea, C., Nicolae, M., Nelson‑Twakor, A., Dumitru, I."Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study". Medicine International 4.3 (2024): 30.
Chicago
Campeanu, A., Rus, M., Ispas, S., Herlo, A., Craciun, A., Ionescu, C., Banariu, G., Cambrea, C., Nicolae, M., Nelson‑Twakor, A., Dumitru, I."Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study". Medicine International 4, no. 3 (2024): 30. https://doi.org/10.3892/mi.2024.154